Get started
Legend Biotech Corp. Sponsored ADRLegend Biotech Corp. Sponsored ADRLegend Biotech Corp. Sponsored ADR

Legend Biotech Corp. Sponsored ADR

No trades
OverviewFinancialsNewsDocumentsCommunityTechnicalsForecastsSeasonalsOptionsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪3.08 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.31 USD
Net income (FY)
‪−177.11 M‬ USD
Revenue (FY)
‪627.56 M‬ USD
Shares float
‪180.91 M‬
Beta (1Y)
0.47

About Legend Biotech Corp. Sponsored ADR


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Ying Huang
Website
legendbiotech.com
Headquarters
Somerset
Founded
2014
IPO date
Jun 5, 2020
Identifiers
3
ISIN US52490G1022
Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Check out other big names from the same industry as LEGN.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


IBB
iShares Biotechnology ETF
Weight
0.20%
Market value
‪16.94 M‬
USD
MCHI
iShares MSCI China ETF
Weight
0.04%
Market value
‪3.27 M‬
USD
EEM
iShares MSCI Emerging Markets ETF
Weight
0.01%
Market value
‪2.99 M‬
USD
KOMP
State Street SPDR S&P Kensho New Economies Composite ETF
Weight
0.08%
Market value
‪1.96 M‬
USD
CANC
Tema Oncology ETF
Weight
1.28%
Market value
‪1.88 M‬
USD
ICHD
iShares MSCI China UCITS ETF USD
Weight
0.04%
Market value
‪1.87 M‬
USD
ICHN
iShares MSCI China UCITS ETF AccumUSD
Weight
0.04%
Market value
‪1.87 M‬
USD
FBCG
Fidelity Blue Chip Growth ETF
Weight
0.02%
Market value
‪1.26 M‬
USD
AEMU
Amundi Core MSCI Emerging Markets -UCITS ETF DR- Distribution
Weight
0.01%
Market value
‪1.26 M‬
USD
AEMD
Amundi Core MSCI Emerging Markets -UCITS ETF DR- Distribution
Weight
0.01%
Market value
‪1.26 M‬
USD
AEME
Amundi Core MSCI Emerging Markets -UCITS ETF DR- Capitalisation
Weight
0.01%
Market value
‪1.26 M‬
USD

Explore more ETFs